Skip to main content
Fig. 4 | Reproductive Biology and Endocrinology

Fig. 4

From: Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany

Fig. 4

Secondary outcomes in the overall population adjusted for possible confounding factors. Differences between study groups were adjusted for possible confounding factors via inverse probability of treatment weighting using a propensity score estimated by boosted regression trees. HR, hazard ratio. *p = 0.548; **p = 0.003

Back to article page